Curanex Pharmaceuticals Inc (CURX) — 8-K Filings

8-K Filings (6)

• Curanex Pharmaceuticals Files 8-K — Apr 2, 2026 Risk: low
  Curanex Pharmaceuticals Inc. filed an 8-K on April 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibit
• Curanex Pharmaceuticals Faces Delisting Notice — Nov 6, 2025 Risk: high
  Curanex Pharmaceuticals Inc. announced on November 5, 2025, that it has received a notice of delisting or failure to satisfy a continued listing rule or standar
• Curanex Pharmaceuticals Reports Unregistered Equity Sales — Sep 29, 2025 Risk: medium
  Curanex Pharmaceuticals Inc. filed an 8-K on September 29, 2025, reporting unregistered sales of equity securities and other events that occurred on September 2
• Curanex Pharmaceuticals Files 8-K — Sep 12, 2025 Risk: low
  Curanex Pharmaceuticals Inc. filed an 8-K on September 12, 2025, reporting other events and financial statements. The company, incorporated in Nevada, has its p
• Curanex Pharmaceuticals Files 8-K — Aug 27, 2025 Risk: low
  Curanex Pharmaceuticals Inc. filed an 8-K on August 27, 2025, reporting under "Other Events" and "Financial Statements and Exhibits." The filing does not contai
• Curanex Pharmaceuticals Enters Material Definitive Agreement — Aug 26, 2025 Risk: medium
  Curanex Pharmaceuticals Inc. announced on August 25, 2025, that it has entered into a material definitive agreement. The company, incorporated in Nevada with it

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX